We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.3B
AUM Growth
-$438M
Cap. Flow
-$385M
Cap. Flow %
-5.28%
Top 10 Hldgs %
23.31%
Holding
3,320
New
46
Increased
2,165
Reduced
525
Closed
74

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$90.2M
2
AFL icon
Aflac
AFL
+$85.3M
3
HSY icon
Hershey
HSY
+$53.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$48.8M
5
ABBV icon
AbbVie
ABBV
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Financials 18.4%
3 Healthcare 12.02%
4 Consumer Discretionary 8.91%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVVD icon
2826
Invivyd
IVVD
$198M
$1.19K ﹤0.01%
2,694
+2,442
+969% +$1.9K
JAMF
2827
DELISTED
Jamf
JAMF
$1.19K ﹤0.01%
85
SOC icon
2828
Sable Offshore Corp
SOC
$976M
$1.19K ﹤0.01%
52
COUR icon
2829
Coursera
COUR
$1.52B
$1.19K ﹤0.01%
140
MGNX icon
2830
MacroGenics
MGNX
$259M
$1.19K ﹤0.01%
366
+282
+336% +$1.02K
WDIV icon
2831
State Street SPDR S&P Global Dividend ETF
WDIV
$279M
$1.18K ﹤0.01%
19
-1
-5% -$65
SLNO
2832
DELISTED
Soleno Therapeutics
SLNO
$1.17K ﹤0.01%
26
+3
+13% +$155
APLT
2833
DELISTED
Applied Therapeutics
APLT
$1.15K ﹤0.01%
1,347
+1,167
+648% +$7.32K
ALHC icon
2834
Alignment Healthcare
ALHC
$2.86B
$1.15K ﹤0.01%
102
CTNM
2835
Contineum Therapeutics
CTNM
$545M
$1.14K ﹤0.01%
78
+65
+500% +$1.03K
HOWL icon
2836
Werewolf Therapeutics
HOWL
$18.6M
$1.14K ﹤0.01%
771
+690
+852% +$1.41K
LNAI
2837
Lunai Bioworks
LNAI
$10.7M
$1.14K ﹤0.01%
17
+16
+1,600% +$1.06K
FGD icon
2838
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.59B
$1.13K ﹤0.01%
51
IMAX icon
2839
IMAX
IMAX
$2.81B
$1.13K ﹤0.01%
44
SNDX icon
2840
Syndax Pharmaceuticals
SNDX
$1.82B
$1.11K ﹤0.01%
84
TELO icon
2841
Telomir Pharmaceuticals
TELO
$80.5M
$1.11K ﹤0.01%
269
+259
+2,590% +$1.22K
INOD icon
2842
Innodata
INOD
$2.03B
$1.11K ﹤0.01%
28
NATH icon
2843
Nathan's Famous
NATH
$400M
$1.1K ﹤0.01%
14
+10
+250% +$846
SDGR icon
2844
Schrodinger
SDGR
$1.4B
$1.1K ﹤0.01%
57
SLND icon
2845
Southland Holdings
SLND
$33M
$1.09K ﹤0.01%
336
+304
+950% +$1.01K
ARLO icon
2846
Arlo Technologies
ARLO
$1.6B
$1.08K ﹤0.01%
97
KFRC icon
2847
Kforce
KFRC
$1.04B
$1.08K ﹤0.01%
19
UVXY icon
2848
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$293M
$1.08K ﹤0.01%
10
SBDS
2849
DELISTED
Solo Brands Inc
SBDS
$1.07K ﹤0.01%
24
+23
+2,300% +$1.14K
RSI icon
2850
Rush Street Interactive
RSI
$2.86B
$1.07K ﹤0.01%
78

Similar funds

Sterling Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sterling Capital Management held 3,320 positions worth $7.3B, down 5.7% from $7.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $385M in Q4 2024, closing 74 positions and reducing 525 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $4.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in iShares Russell 1000 Value ETF worth $10.5M.

  • Sterling Capital Management's largest Q4 2024 buy was iShares Russell 1000 Value ETF: 56,923 shares worth $10.5M.
  • Sterling Capital Management added most to Everest Group in Q4 2024, an estimated $103M increase.
  • Sterling Capital Management's biggest Q4 2024 reduction was Nasdaq, cutting an estimated $90.2M.
  • Sterling Capital Management fully exited iShares Russell 1000 Growth ETF in Q4 2024, selling an estimated $4.12M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $7.3B portfolio in Q4 2024.
  • Sterling Capital Management opened 46 new positions and closed 74 in Q4 2024.
  • Sterling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $7.3B.

Based on Sterling Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.